Cato Research appoints new president

Mr Cline comes to Cato Research from Etrials Worldwide, where he most recently served as president and CEO. Mr Cline has over 25 years experience in the pharmaceutical industry, including senior sales and marketing roles at Organon, Caremark, a division of Baxter, and MiniDoc.

Allen Cato, CEO of Cato Research, said: “John Cline brings extensive leadership experience to Cato Research. His industry skills and vision for helping pharmaceutical and biotechnology companies bring new drugs to market efficiently and cost-effectively complement the strategic direction and unique business model Lynda Sutton and I have charted for Cato Research.”